These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 27126552)

  • 1. A machine learning-based approach for improving plasmid DNA production in Escherichia coli fed-batch fermentations.
    Xu Z; Zhu X; Mohsin A; Guo J; Zhuang Y; Chu J; Guo M; Wang G
    Biotechnol J; 2024 Jun; 19(6):e2400140. PubMed ID: 38896410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online bioprocess data generation, analysis, and optimization for parallel fed-batch fermentations in milliliter scale.
    Nickel DB; Cruz-Bournazou MN; Wilms T; Neubauer P; Knepper A
    Eng Life Sci; 2017 Nov; 17(11):1195-1201. PubMed ID: 32624747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upstream development of Escherichia coli fermentation process with PhoA promoter using design of experiments (DoE).
    Agbogbo FK; Ramsey P; George R; Joy J; Srivastava S; Huang M; McCool J
    J Ind Microbiol Biotechnol; 2020 Oct; 47(9-10):789-799. PubMed ID: 32844325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process adapted calibration improves fluorometric pH sensor precision in sophisticated fermentation processes.
    Newton J; Oeggl R; Janzen NH; Abad S; Reinisch D
    Eng Life Sci; 2020 Aug; 20(8):331-337. PubMed ID: 32774205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giving the cells what they need when they need it: Biosensor-based feeding control.
    Kinet R; Richelle A; Colle M; Demaegd D; von Stosch M; Sanders M; Sehrt H; Delvigne F; Goffin P
    Biotechnol Bioeng; 2024 Apr; 121(4):1271-1283. PubMed ID: 38258490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COSMIC-dFBA: A novel multi-scale hybrid framework for bioprocess modeling.
    Gopalakrishnan S; Johnson W; Valderrama-Gomez MA; Icten E; Tat J; Ingram M; Fung Shek C; Chan PK; Schlegel F; Rolandi P; Kontoravdi C; Lewis NE
    Metab Eng; 2024 Mar; 82():183-192. PubMed ID: 38387677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to mitigate
    Mathur H; Mechoud MA; Matthews C; Lordan C; FitzGerald JA; Beresford T; Cotter PD
    MethodsX; 2023 Dec; 11():102393. PubMed ID: 37846356
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioavailability studies and anticancer properties of malvidin based anthocyanins, pyranoanthocyanins and non-oxonium derivatives.
    Oliveira H; Wu N; Zhang Q; Wang J; Oliveira J; de Freitas V; Mateus N; He J; Fernandes I
    Food Funct; 2016 May; 7(5):2462-8. PubMed ID: 27165855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying intensified design of experiments to mammalian cell culture processes.
    Nold V; Junghans L; Bisgen L; Drerup R; Presser B; Gorr I; Schwab T; Knapp B; Wieschalka S
    Eng Life Sci; 2022 Dec; 22(12):784-795. PubMed ID: 36514527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History and Evolution of Modeling in Biotechnology: Modeling & Simulation, Application and Hardware Performance.
    Noll P; Henkel M
    Comput Struct Biotechnol J; 2020; 18():3309-3323. PubMed ID: 33240472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensified design of experiments for upstream bioreactors.
    von Stosch M; Willis MJ
    Eng Life Sci; 2017 Nov; 17(11):1173-1184. PubMed ID: 32624745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Working within the Design Space: Do Our Static Process Characterization Methods Suffice?
    von Stosch M; Schenkendorf R; Geldhof G; Varsakelis C; Mariti M; Dessoy S; Vandercammen A; Pysik A; Sanders M
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32560435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study.
    von Stosch M; Hamelink JM; Oliveira R
    Bioprocess Biosyst Eng; 2016 May; 39(5):773-84. PubMed ID: 26879643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel steady state studies on a milliliter scale accelerate fed-batch bioprocess design for recombinant protein production with Escherichia coli.
    Schmideder A; Cremer JH; Weuster-Botz D
    Biotechnol Prog; 2016 Nov; 32(6):1426-1435. PubMed ID: 27604066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations.
    Li J; Jaitzig J; Lu P; Süssmuth RD; Neubauer P
    Microb Cell Fact; 2015 Jun; 14():83. PubMed ID: 26063334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growing E. coli to high cell density--a historical perspective on method development.
    Shiloach J; Fass R
    Biotechnol Adv; 2005 Jul; 23(5):345-57. PubMed ID: 15899573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward intensifying design of experiments in upstream bioprocess development: An industrial Escherichia coli feasibility study.
    von Stosch M; Hamelink JM; Oliveira R
    Biotechnol Prog; 2016 Sep; 32(5):1343-1352. PubMed ID: 27126552
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.